跳至主要内容
临床试验/NCT04780763
NCT04780763已完成不适用

Effect of 4-week Oral Administration of a Fermented Dairy Product Containing Lactobacillus Rhamnosus CNCM I-3690, on Subjective State Anxiety Levels in Healthy Women Undergoing Academic Stress. A Proof-of-efficacy, Randomized, Controlled, Double-blind, Monocentric, Parallel Arms Design Study.

Danone Research2 个研究点 分布在 1 个国家目标入组 168 人开始时间: 2021年3月4日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
168
试验地点
2
主要终点
Comparison between groups of the State-Trait Anxiety Inventory (STAI)-state questionnaire score during 4 weeks of investigational product consumption.

研究概览

简要总结

The purpose of this study is to assess the effect of Lactobacillus rhamnosus CNCM I-3690 consumption on subjective anxiety levels in healthy subjects undergoing academic stress.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

The study Test and Control products have been developed in order to guarantee the blinding, they will be similar by their taste, texture, color, packaging, nutritional content and flavor.

The blinding of study products will be performed by assigning a study product number corresponding to the randomization list. Then blinded study product packages will then be carried to the investigational site for assignment to the subject.

Product allocation will be performed by randomized method (IWRS validated system) as a Randomized Controlled Trial. The participants are thus assigned to intervention groups randomly.

入排标准

年龄范围
20 Years 至 30 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • SI01: Free-living Participant who fully understands and agree to the objectives of the study, who gave signed and dated informed consent
  • SI02: Women of 20 to 30 years of age inclusive
  • SI03: Participants who are healthy as determined by medical evaluation including medical and surgical history and full physical examination.
  • SI04: Body mass index (BMI) within the range 18 and 30 kg/m2 (bounds included).
  • SI05: Woman participants.
  • SI06: Student defending a bachelor's or master's thesis in front of a jury
  • SI07: Subject who regularly consumes dairy fermented products containing live bacteria and willing to consume 2 units of investigational product per day during the study.
  • SI08: Subject willing to strictly follow instructions on diet, medication and substance use for the entire duration of the study.

排除标准

  • SE01: subject with chronic gastrointestinal disorders or symptoms, with celiac disease, diagnosed type 1 or type 2 diabetes mellitus, with psychiatric disease including but not limited to depression and general anxiety disorder
  • SE03: subject with food allergy, history of atopic conditions (eczema, allergic asthma, allergic rhino conjunctivitis) requiring active treatment, with first degree relatives with coeliac disease, inflammatory bowel disease (IBD) or type 1 diabetes, with known or suspected lactose intolerance
  • SE4: Subject with eating disorders, chronic or iatrogenic immunodeficiency (e.g. Chemotherapy, HIV), presenting a severe evolutive or chronic pathology (e.g. cancer, tuberculosis, Crohn's disease, cirrhosis, multiple sclerosis)
  • SE5: Subject with cardiac, respiratory (including asthma) or renal insufficiency, cardiomyopathy, valvulopathy and medical history of rheumatic fever and/or with a positive test for COVID-19 infection or presenting any symptoms of COVID infection in the past 2 weeks
  • SE6: Subject receiving systemic treatment or topical treatment likely to interfere with evaluation of the study parameters (antibiotics, intestinal or respiratory antiseptics, anti-rheumatics, and steroids prescribed in chronic inflammatory diseases, antiphlogistic, anti-inflammatory and PPIs)
  • SE7: Subject who has planned to participate in another investigational study OR subject involved in any other clinical study within the preceding month
  • SE8: Subjects planning to significantly change their diet during the period of the study or who have changed his/her dietary habits within the 4 weeks preceding the study (e.g. start of a diet high in fibres)
  • SE9: Pregnant woman or woman planning to become pregnant during the study; breast-feeding woman.

结局指标

主要结局

Comparison between groups of the State-Trait Anxiety Inventory (STAI)-state questionnaire score during 4 weeks of investigational product consumption.

时间窗: At Baseline and after stress challenge (4 weeks after baseline).

次要结局

  • Comparison between groups of cortisol level in saliva, Perceived Stress Scale (PSS) questionnaire score and Heart Rate Variability (HRV) during 4 weeks of investigational product consumption.(At Baseline and after stress challenge (4 weeks from baseline).)
  • Comparison between groups of cortisol levels in saliva after 4 weeks of investigational product consumption.(Time course of cortisol secretion on the day of the stress challenge (5 timepoints).)
  • Comparison between groups of sleep efficiency, total sleep time, and deep sleep (Non-REM 3 sleep cycle) duration, during 4 weeks of investigational product consumption.(At Baseline and at stress challenge (4 weeks from baseline).)
  • Comparison between groups of Bond-Lader visual analogue scale (VAS) score during 4 weeks of investigational product consumption.(At Baseline and at stress challenge (4 weeks from baseline).)

研究者

发起方
Danone Research
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验